glp-1 aspiration How should we approach patients on agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the Guidelines and Decoding the Enigma: Strategies for Anesthetic Management of Patients on Glucagon-Like A narrative review of glucagon-like

also approved for chronic weight management in adults (refer to current MHRA and NICE Technology Appraisal guidance for the applicable indication and eligibility criteria) [4] [7] Orlistat available on NHS prescription and over the counter Naltrexone/bupropion (Mysimba) available in some settings, though NHS commissioning varies by region [10] NICE Technology Appraisals provide eligibility criteria and commissioning guidance for semaglutide and tirzepatide in weight management

Meanwhile, Semaglutide GLP-1 (Ozempic, Wegovy) has shown promising results in terms of weight loss, despite its primary use for treating type 2 diabetes

Genetic factors, baseline metabolic health, dietary compliance, physical activity levels, and even gut microbiome composition likely contribute to this variability

6 The use of GLP-1RAs is also associated with a lower risk of adverse cardiac events, such as myocardial infarction and stroke